<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35059196</PMID><DateRevised><Year>2022</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-9361</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Therapeutic advances in infectious disease</Title><ISOAbbreviation>Ther Adv Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City.</ArticleTitle><Pagination><StartPage>20499361211069264</StartPage><MedlinePgn>20499361211069264</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20499361211069264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/20499361211069264</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Several reports have emerged describing the long-term consequences of COVID-19 and its effects on multiple systems.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">As further research is needed, we conducted a longitudinal observational study to report the prevalence and associated risk factors of the long-term health consequences of COVID-19 by symptom clusters in patients discharged from the Temporary COVID-19 Hospital (TCH) in Mexico City. Self-reported clinical symptom data were collected <i>via</i> telephone calls over 90 days post-discharge. Among 4670 patients, we identified 45 symptoms across eight symptom clusters (neurological; mood disorders; systemic; respiratory; musculoskeletal; ear, nose, and throat; dermatological; and gastrointestinal).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed that the neurological, dermatological, and mood disorder symptom clusters persisted in &gt;30% of patients at 90 days post-discharge. Although most symptoms decreased in frequency between day 30 and 90, alopecia and the dermatological symptom cluster significantly increased (<i>p</i>&#x2009;&lt;&#x2009;0.00001). Women were more prone than men to develop long-term symptoms, and invasive mechanical ventilation also increased the frequency of symptoms at 30 days post-discharge.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall, we observed that symptoms often persisted regardless of disease severity. We hope these findings will help promote public health strategies that ensure equity in the access to solutions focused on the long-term consequences of COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong-Chew</LastName><ForeName>Rosa Mar&#xed;a</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Cabrera</LastName><ForeName>Edwin Xchel</ForeName><Initials>EX</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Valdez</LastName><ForeName>Carlos Alberto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomelin-Gascon</LastName><ForeName>Julieta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales-Ju&#xe1;rez</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de la Cerda</LastName><ForeName>Mariana Lizbeth Rodr&#xed;guez</ForeName><Initials>MLR</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa-Romero</LastName><ForeName>Antonio Rafael</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arce Fern&#xe1;ndez</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serratos Fernandez</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bello</LastName><ForeName>H&#xe9;ctor Herrera</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casta&#xf1;eda</LastName><ForeName>Lidia Moreno</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avenda&#xf1;o</LastName><ForeName>M&#xf3;nica Arboleya</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Cruz</LastName><ForeName>Jes&#xfa;s Abraham</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez Mart&#xed;nez</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernanda Contreras</LastName><ForeName>Liza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafael Gonz&#xe1;lez de la Cerda</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ju&#xe1;rez Flores</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Juarez</LastName><ForeName>Luis Alberto</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0001-7550-7867</Identifier><AffiliationInfo><Affiliation>Carlos Slim Foundation, Mexico City, MexicoLondon School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Hern&#xe1;ndez</LastName><ForeName>Diego-Abelardo</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0003-2340-6639</Identifier><AffiliationInfo><Affiliation>Carlos Slim Foundation, Mexico City, MexicoLondon School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallardo-Rinc&#xf3;n</LastName><ForeName>H&#xe9;ctor</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0811-4606</Identifier><AffiliationInfo><Affiliation>Health Sciences University Center, University of Guadalajara, Sierra Mojada 950, Independencia Oriente, 44340 Guadalajara, Jalisco, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fajardo Dolci</LastName><ForeName>German</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tapia-Conyer</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Autonomous University of Mexico, Mexico City, MexicoCarlos Slim Foundation, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdez-V&#xe1;zquez</LastName><ForeName>Rafael Ricardo</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Temporary COVID-19 Hospital, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Infect Dis</MedlineTA><NlmUniqueID>101606715</NlmUniqueID><ISSNLinking>2049-9361</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mexico</Keyword><Keyword MajorTopicYN="N">long-covid</Keyword><Keyword MajorTopicYN="N">post COVID-19</Keyword><Keyword MajorTopicYN="N">symptom cluster</Keyword></KeywordList><CoiStatement>Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The Carlos Slim Foundation funded this study. The funding source was involved in the design of the study, analysis, interpretation of data, and in writing the manuscript. R.R.V.V., E.X.R.C., C.A.R.V., M.L.R.C., S.A.F., M.S.F., H.H.B., L.M.C., M.A.A., J.A.H.C., N.A.M., L.F.C., L.R.G.C., and A.J.F. are employees of the Temporary COVID-19 Hospital. J.L.G., L.M.J., L.A.M.J., D-A.A-H., H.G-R., and R.T-C. are employees of The Carlos Slim Foundation. All authors confirm that they had full access to all the study data and accept responsibility to submit for publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35059196</ArticleId><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="doi">10.1177/20499361211069264</ArticleId><ArticleId IdType="pii">10.1177_20499361211069264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard, https://covid19.who.int/ (2021, accessed 14 September 2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">37184163</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gobierno de la Ciudad de Mexico. Covid-19 CDMX, https://cdmx.dash.covid19.geoint.mx (2021, accessed 9 November 2021).</Citation></Reference><Reference><Citation>Han E, Tan MMJ, Turk E, et al.. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet 2020; 396: 1525&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515628</ArticleId><ArticleId IdType="pubmed">32979936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al.. Attributes and predictors of long COVID. Nat Med 2021; 27: 626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al.. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2020; 76: 399&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al.. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021; 27: 258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, et al.. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis 2021; 21: 313&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, et al.. Neurological associations of COVID-19. Lancet Neurol 2020; 19: 767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, et al.. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 2020; 143: 3104&#x2013;3120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021; 397: 220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6
October
2021, https://www.who.Int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021, accessed 17 November 2021).</Citation></Reference><Reference><Citation>Norton A, Olliaro P, Sigfrid L, et al.. Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis 2021; 21: 601&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Juarez LA, Sedas AC, Orcutt M, et al.. Governments and international institutions should urgently attend to the unjust disparities that COVID-19 is exposing and causing. EClinicalMedicine 2020; 23: 100376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272149</ArticleId><ArticleId IdType="pubmed">32632411</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al.. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27: 89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med 2021; 174: 576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med 2021; 21: e68&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, David AS. A longer look at COVID-19 and neuropsychiatric outcomes. Lancet Psychiatry 2021; 8: 351&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023693</ArticleId><ArticleId IdType="pubmed">33836149</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, et al.. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8: 416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al.. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11: 16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro CM, Rossi A, Poe J, et al.. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia. J Drugs Dermatol 2011; 10: 1404&#x2013;1411.</Citation><ArticleIdList><ArticleId IdType="pubmed">22134564</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyravian N, Deo S, Daunert S, et al.. The inflammatory aspect of male and female pattern hair loss. J Inflamm Res 2020; 13: 879&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667670</ArticleId><ArticleId IdType="pubmed">33204138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieczkowska K, Deutsch A, Borok J, et al.. Telogen effluvium: a sequela of COVID-19. Int J Dermatol 2021; 60: 122&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753411</ArticleId><ArticleId IdType="pubmed">33226117</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallanti S, Grassi E, Makris N, et al.. Neurocovid-19: a clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae. J Psychiatr Res 2020; 130: 215&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428715</ArticleId><ArticleId IdType="pubmed">32836010</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, et al.. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost 2021; 19: 1064&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, et al.. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses 2020; 144: 110055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, Ciaffi J, Mancarella L, et al.. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open 2021; 7: e001735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x2018;long-haulers&#x2019;? Chronic Dis Transl Med 2021; 7: 14&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses 2021; 146: 110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>